satyamkapoor

I work at ValueFirst Digital Media Private Ltd. I am a Product Marketer in the Surbo Team. Surbo is Chatbot Generator Platform owned by Value First. ...

Full Bio 

I work at ValueFirst Digital Media Private Ltd. I am a Product Marketer in the Surbo Team. Surbo is Chatbot Generator Platform owned by Value First.

Success story of Haptik
583 days ago

Who is afraid of automation?
583 days ago

What's happening in AI, Blockchain & IoT
584 days ago

3 million at risk from the rise of robots
584 days ago

5 ways Machine Learning can save your company from a security breach
584 days ago

Google Course for IT beginners, certificate in 8 months: Enrollment starts on Coursera today, check details
33156 views

7 of the best chatbot building plaftorms out there
22182 views

Could your job be taken over by Artificial Intelligence?
21249 views

IIT Madras launches Winter Course on Machine Intelligence and Brain Research
18840 views

WILL ROBOTS FIGHT THE NEXT WAR? U.S. AND RUSSIA BRING ARTIFICIAL INTELLIGENCE TO THE BATTLEFIELD
17778 views

Malaria Killer found in common toothpaste ingredient by British AI robot

By satyamkapoor |Email | Jan 19, 2018 | 7206 Views

A British University's artificial intelligent robot has become a big hero after it played a role in helping scientists find a malaria killer in a common toothpaste ingredient as per a new study revealed.
University of Cambridge scientists used this robot - Eve, in a high-throughput screen & discovered that triclosan, an ingredient found in many toothpastes, could possibly help fight against strains of malaria parasite that have grown resistant to one of the drugs being currently used to treat the disease.

The findings of the study by the Cambridge researchers were published in the journal Scientific Reports on Thursday.

With the help of the AI-powered Eve, the researchers discovered that triclosan inhibits the spread of a kind of enzyme of the malaria parasite, called DHFR, thus stopping the growth of the parasite in the blood.

The discovery challenged a previous assumption that triclosan inhibits the growth in culture of the malaria parasite Plasmodium during the blood-stage, because it is targeting an enzyme known as enoyl reductase (ENR) found in the liver.

The Cambridge scientists discovered that triclosan was able to target and act on the DHFR enzyme even in parasites that were resistant to the antimalarial drug, pyrimethamine.

Malaria is spread to humans by the bites of a mosquito infected with malaria parasites that are transferred into their bloodstream via its saliva.

The parasites mature and reproduce in the liver of humans, which eventually hijack red blood cells and spread around the body, causing symptoms and even life-threatening complications.

With the new function of triclosan, which inhibits both ENR and DHFR, the researchers believe it is possible that the parasite may be targeted at both the liver stage and the later blood stage.

"The discovery by our robot 'colleague' Eve that triclosan is effective against malaria targets offers hope that we may be able to use it to develop a new drug," said Elizabeth Bilsland, lead author of the study.

Robot Eve was developed by a group of scientists at the British universities of Manchester, Aberystwyth in Wales, and Cambridge.

This development was led by a professor from University of Manchester named Ross King.
It speeds up and automates the drug discovery process, including auto testing of the hypothesis in order to explain observations, running experiments and automating high-throughput hypothesis-led research.
It is possible to create "automated scientists" that can take an intelligent approach science using AI and machine learning. This could greatly speed up the drug discovery process according to King. 

Source: HOB